Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
FTXH
49
HOLDINGS
15%
ALSO IN THNR
THNR
20
HOLDINGS
35%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 7.5% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 7.0% | 5.5% | 5.5% |
|
PFIZER INC | 7.3% | 5.4% | 5.4% |
|
GILEAD SCIENCES INC | 3.7% | 5.3% | 3.7% |
|
AMGEN INC | 3.5% | 6.8% | 3.5% |
FTXH Overweight Relative to THNR
|
JOHNSON & JOHNSON | 8.1% |
|
BRISTOL-MYERS SQUIBB CO | 6.0% |
|
VIATRIS, INC. | 4.3% |
|
BIOGEN IDEC INC | 3.7% |
|
UNITED THERAPEUTICS CORP | 3.6% |
|
ZOETIS INC | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.2% |
|
ELANCO ANIMAL HEALTH, INC. | 2.7% |
|
MEDPACE HOLDINGS, INC. | 2.6% |
|
CHARLES RIVER LABORATORIES | 2.1% |
FTXH Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -9.1% |
|
ELI LILLY & CO | -8.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
 |
INNOVENT BIOLOGICS, INC. | -5.2% |
 |
ROCHE HOLDING LTD | -5.0% |
 |
CHINA PHARMACEUTICAL GROUP | -4.9% |
|
REGENERON PHARMACEUTICALS | -4.7% |
|
SHIONOGI & CO LTD | -4.3% |
|
AMGEN INC | -3.3% |